Loading…
Tyra Biosciences, Inc. is projected to rise to $37.78 by 2027, a +14% move from its current price of $33.06. TYRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $32.27 | $33.08 | $33.90 | +0.05% |
| Aug 2 | $31.96 | $33.09 | $34.26 | +0.10% |
| Aug 3 | $31.73 | $33.11 | $34.55 | +0.15% |
| Aug 4 | $31.54 | $33.13 | $34.80 | +0.21% |
| Aug 5 | $31.37 | $33.15 | $35.02 | +0.26% |
| Aug 6 | $31.22 | $33.16 | $35.22 | +0.31% |
| Aug 7 | $31.09 | $33.18 | $35.41 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.09 | $33.18 | $35.41 | +0.36% |
| Week 2 | $30.37 | $33.30 | $36.51 | +0.72% |
| Week 3 | $29.86 | $33.42 | $37.41 | +1.09% |
| Week 4 | $29.45 | $33.54 | $38.20 | +1.45% |
| Week 5 | $29.11 | $33.66 | $38.93 | +1.82% |
| Week 6 | $28.81 | $33.78 | $39.62 | +2.19% |
| Week 7 | $28.55 | $33.91 | $40.27 | +2.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on FGFR biology in the United States. It develops precision medicines and offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.
Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200 for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma.
Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
The stock price is $33.06 and the market cap is $1.97B, with a rank of 1920.
Near term, the 2026 forecast shows a min of $25.42, an average of $33.06, a max of $43.22, an ROI of 0, and a sentiment of NEUTRAL.
Looking further out, the forecast path rises steadily: 2027 avg $37.78, 2028 avg $39.35, 2029 avg $45.71, 2030 avg $51.50, 2031 avg $58.91, 2032 avg $71.42, 2033 avg $74.66, 2034 avg $76.45, 2035 avg $83.33, 2040 avg $132.18, and 2050 avg $235.20, with max forecasts reaching $73.31 in 2030 and $418.46 in 2050. The implied ROIs scale to 55.8%, 299.8%, and 611.4% for later milestones, with a bullish sentiment prevailing in the long horizon.
A major floor 23.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 19.8% above — clearing it would confirm fresh momentum.
Key TYRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TYRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $31.35 | Buy | $31.70 | Buy |
| MA 10 | $31.32 | Buy | $31.53 | Buy |
| MA 20 | $31.72 | Buy | $31.40 | Buy |
| MA 50 | $30.66 | Buy | $31.52 | Buy |
| MA 100 | $33.37 | Sell | $31.28 | Buy |
| MA 200 | $28.78 | Buy | $28.40 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.59 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 111.26 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.55 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 0.52 | Buy |
| Ultimate (7,14,28) | 60.12 | Neutral |
| Momentum (10) | 1.45 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 31.60 | Buy |
| ADX (14) | 10.69 | Neutral |
| ATR (14) | 0.69 | Info |
The 30-day technical picture is BULLISH.
RSI14 is 60, and the stock trades above both the SMA50 of $30.66 and the SMA200 of $28.78.
Key support sits at $28.32 and resistance at $33.06, with a 30-day price range of $28.11 to $38.88.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $25.42 | $33.06 | $43.22 | 0% | Neutral | |
| $30.40 | $37.78 | $49.46 | +14% | Neutral | |
| $30.88 | $39.35 | $53.32 | +19% | Neutral | |
| $35.13 | $45.71 | $63.61 | +38% | Bullish | |
| $38.87 | $51.50 | $73.31 | +56% | Bullish | |
| $43.73 | $58.91 | $85.51 | +78% | Bullish | |
| $52.22 | $71.42 | $105.53 | +116% | Bullish | |
| $53.81 | $74.66 | $112.10 | +126% | Bullish | |
| $54.35 | $76.45 | $116.48 | +131% | Bullish | |
| $58.48 | $83.33 | $128.71 | +152% | Bullish | |
| $87.48 | $132.18 | $216.23 | +300% | Bullish | |
| $140.91 | $235.20 | $418.46 | +611% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $25.42 | $33.06 | $38.56 | +0.00% |
| August 2026 | $29.26 | $34.27 | $41.02 | +3.66% |
| September 2026 | $29.37 | $34.65 | $41.98 | +1.11% |
| October 2026 | $28.69 | $34.06 | $41.65 | -1.72% |
| November 2026 | $28.73 | $34.28 | $42.25 | +0.66% |
| December 2026 | $29.05 | $34.82 | $43.22 | +1.58% |
Click any year to see its month-by-month TYRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TYRA to range from $25.42 to $43.22 through 2026. The $33.06 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TYRA price prediction for 2027 points to an average of $37.78 (low $30.40, high $49.46) — a potential gain of +14% on today's $33.06. Price action looks broadly range-bound.
In 2028, TYRA is projected to trade between $30.88 and $53.32, averaging $39.35 — a potential gain of +19% from today's $33.06. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
Tyra Biosciences, Inc.'s 2029 outlook centres on $45.71, within a $35.13 to $63.61 range. That is up +16% on the projected 2028 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2030, TYRA could reach as high as $73.31, with a base case around $51.50 and support toward $38.87 — roughly +56% from $33.06. Buyers look set to stay in control over this stretch.
Expect TYRA to range from $43.73 to $85.51 through 2031. The $58.91 average target implies a +78% move from current prices. That is up +14% on the projected 2030 average. Momentum favours further upside here.
The TYRA price prediction for 2032 points to an average of $71.42 (low $52.22, high $105.53) — a potential gain of +116% on today's $33.06. Buyers look set to stay in control over this stretch.
In 2033, TYRA is projected to trade between $53.81 and $112.10, averaging $74.66 — a potential gain of +126% from today's $33.06. That is up +5% on the projected 2032 average. Momentum favours further upside here.
Tyra Biosciences, Inc.'s 2034 outlook centres on $76.45, within a $54.35 to $116.48 range. That is up +2% on the projected 2033 average. That marks a +131% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TYRA could reach as high as $128.71, with a base case around $83.33 and support toward $58.48 — roughly +152% from $33.06. Momentum favours further upside here.
Expect TYRA to range from $87.48 to $216.23 through 2040. The $132.18 average target implies a +300% move from current prices. That is up +59% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TYRA price prediction for 2050 points to an average of $235.20 (low $140.91, high $418.46) — a potential gain of +611% on today's $33.06. Momentum favours further upside here.
Investing $1,000 in TYRA today (≈ 30.248034 TYRA) could be worth
$7,114.26
+$6,114.26 (+611%) by 2050 · US Dollar
Based on the average projected TYRA price of $235.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TYRAwould be worth at today's price.
$1,000 invested in TYRA on Jul 30, 2025 (≈ 89.686102 TYRA) would be worth
$2,965.02
+$1,965.02 (+196.5%) today · 2.97× · US Dollar
Based on a TYRA entry price of $11.15 vs. today's $33.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $30.8 | $1,073.38 | +7.3% |
| 1 month ago | $31.94 | $1,035.07 | +3.5% |
| 3 months ago | $34.04 | $971.21 | -2.9% |
| 6 months ago | $30.82 | $1,072.68 | +7.3% |
| 1 year ago | $11.15 | $2,965.02 | +196.5% |
| All time (4.9y) ago | $26 | $1,271.54 | +27.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TYRA forecast.
Our base-case forecast reaches $66.00 around 2032.
Implied market cap at $66.00: $3.93B
The multi-year forecast shows a bullish trajectory, with 2030 avg $51.50 and ROI 55.8%, 2040 avg $132.18 and ROI 299.8%, and 2050 avg $235.20 and ROI 611.4%.
Tap a question to reveal the answer.
2030 min $38.87, avg $51.50, max $73.31 with ROI 55.8% and sentiment BULLISH.
Forecasts indicate a rising price path with averages climbing from $33.06 in 2026 toward $51.50 by 2030 and $235.20 by 2050, with ROIs of 55.8% and 611.4%; sentiment is BULLISH in later years, but these are estimates and not guaranteed.
Yes—2032 max is $105.53, and 2033 max is $112.10, 2034 max is $116.48, and 2035 max is $128.71, indicating potential to surpass $100 within the forecast window.
$1.97B.
Tyra Biosciences, Inc. Community Discussion
0Share your Tyra Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.